Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

E Wood, JSG Montaner, B Yip, MW Tyndall… - Cmaj, 2003 - Can Med Assoc
Background: The benefits of highly active antiretroviral therapy (HAART) for the treatment of
HIV infection are well documented, but concerns regarding access and adherence to …

Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting

S Nolan, MJ Milloy, R Zhang, T Kerr, RS Hogg… - AIDS care, 2011 - Taylor & Francis
HIV-positive individuals who use injection drugs (IDU) may have lower rates of adherence to
highly active antiretroviral therapy (ART). However, previous studies of factors associated …

Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use

A Palepu, M Tyndall, B Yip… - JAIDS Journal of …, 2003 - journals.lww.com
Injection drug users who continue to use drugs may not respond to highly active
antiretroviral therapy (HAART) as well as other HIV-infected individuals, even after adjusting …

Adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy

S Viswanathan, AC Justice, GC Alexander… - JAIDS Journal of …, 2015 - journals.lww.com
Background: We examined trends in adherence to highly active antiretroviral therapy
(HAART) and HIV RNA suppression and estimated the minimum cutoff of adherence to …

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users

DD Celentano, N Galai, AK Sethi, NG Shah… - Aids, 2001 - journals.lww.com
Objective Studies have shown that HIV-infected injection drug users (IDUs) are less likely to
receive antiretroviral therapy than non-drug users. We assess factors associated with …

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

A Palepu, B Yip, C Miller, SA Strathdee… - Aids, 2001 - journals.lww.com
Studies have found that HIV-positive injection drug users appear to have a lower uptake of
highly active antiretroviral therapy (HAART) compared with other HIV-positive individuals in …

Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America

BL Genberg, IB Wilson, DR Bangsberg, J Arnsten… - Aids, 2012 - journals.lww.com
Objective: Adherence to antiretroviral therapies (ART) is the strongest predictor of viral
suppression among individuals infected with HIV, however, limited data exists to understand …

Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART)

S Viswanathan, R Detels, SH Mehta… - AIDS and Behavior, 2015 - Springer
The need to achieve≥ 95% adherence to HAART for treatment effectiveness may be a
barrier for universal initiation at early stages of HIV. Using longitudinal data collected from …

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy

A Palepu, MW Tyndall, R Joy, T Kerr, E Wood… - Drug and alcohol …, 2006 - Elsevier
OBJECTIVE: We examined the association of methadone maintenance therapy (MMT) with
highly active antiretroviral therapy (HAART) adherence and HIV treatment outcomes among …

Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort

LM Kuyper, E Wood, JSG Montaner, B Yip… - JAIDS Journal of …, 2004 - journals.lww.com
Background: There have been growing concerns about possible gender-related differences
in rates of responses to highly active antiretroviral therapy (HAART). We therefore examined …